PMDA drug package insert
ソホノスカプセル1mg
PMDA Prescription drug · IPSEN株式会社 · package insert Aug 28, 2026
Key facts
| Brand names | ソホノスカプセル1mg, ソホノスカプセル1.5mg, ソホノスカプセル2.5mg, ソホノスカプセル5mg, ソホノスカプセル10mg |
|---|---|
| Nonproprietary names | パロバロテン |
| Companies | 製造販売元／IPSEN株式会社 |
| Product type | Prescription drug |
| Therapeutic category | レチノイン酸受容体γ作動薬 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999069M1023, 3999069M2020, 3999069M3026, 3999069M4022, 3999069M5029 |
| Approval numbers | 30800AMX00076000, 30800AMX00077000, 30800AMX00078000, 30800AMX00079000, 30800AMX00080000 |
| Package insert edition | 第3版 |
| Package insert date | Aug 28, 2026 |
| PMDA document key | 151077_3999069M1023_1 |
| PMDA company code | 151077 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: